| Genomic Comparison of Escherichia coli O104:H4 Isolates from 2009 and 2011 Reveals Plasmid, and Prophage Heterogeneity, Including Shiga Toxin Encoding … SA Ahmed, J Awosika, C Baldwin, KA Bishop-Lilly, B Biswas, S Broomall, ... PloS one 7 (11), e48228, 2012 | 136 | 2012 |
| Mortality and causes of death among HIV-infected individuals in the country of Georgia: 1989–2012 N Chkhartishvili, L Sharvadze, O Chokoshvili, N Bolokadze, N Rukhadze, ... AIDS research and human retroviruses 30 (6), 560-566, 2014 | 39 | 2014 |
| Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents DM Byonanebye, MN Polizzotto, M Law, K Petoumenos, N Rose, ... Aids 35 (Supplement 2), 869-882, 2021 | 35 | 2021 |
| The cascade of care in the E astern E uropean country of G eorgia N Chkhartishvili, L Sharavdze, O Chokoshvili, JA DeHovitz, C Del Rio, ... HIV medicine 16 (1), 62-66, 2015 | 30 | 2015 |
| Late presentation of HIV infection in the country of Georgia: 2012-2015 N Chkhartishvili, O Chokoshvili, N Bolokadze, M Tsintsadze, L Sharvadze, ... PLoS One 12 (10), e0186835, 2017 | 25 | 2017 |
| Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services M Dara, S Ehsani, A Mozalevskis, E Vovc, D Simões, AA Calvo, ... The Lancet Infectious Diseases 20 (2), e47-e53, 2020 | 23 | 2020 |
| Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium DM Byonanebye, MN Polizzotto, B Neesgaard, M Sarcletti, R Matulionyte, ... HIV medicine 23 (8), 895-910, 2022 | 18 | 2022 |
| Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia N Chkhartishvili, L Sharvadze, N Dvali, M Karchava, N Rukhadze, ... AIDS Research and Therapy 11, 1-6, 2014 | 18 | 2014 |
| Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome O Chokoshvili, K Lomashvili, N Malakmadze, M Geleishvil, J Brant, ... Journal of epidemiology and global health 4 (4), 249-259, 2014 | 17 | 2014 |
| Outcomes of universal access to antiretroviral therapy (ART) in Georgia T Tsertsvadze, N Chkhartishvili, L Sharvadze, N Dvali, O Chokoshvili, ... AIDS research and treatment 2011, 2011 | 13 | 2011 |
| An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia’s corrections system, December 2013–April 2015 AM Harris, O Chokoshvili, J Biddle, K Turashvili, M Japaridze, ... BMC Public Health 19, 1-7, 2019 | 9 | 2019 |
| Experience of antiretroviral treatment in Georgia T Tsertsvadze, N Bolokadze, N Gochitashvili, L Sharvadze, O Chokoshvili, ... Central european journal of public health 17 (1), 25, 2009 | 7 | 2009 |
| Significant improvements are needed in HIV care continuum to meet 90-90-90 targets in Georgia N Chkhartishvili, O Chokoshvili, N Dvali, A Abutidze, L Sharvadze, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2016 | 5 | 2016 |
| Estimating HIV incidence in eastern European country of Georgia: 2010–2012 T Tsertsvadze, N Chkhartishvili, N Dvali, M Karchava, O Chokoshvili, ... International journal of STD & AIDS 25 (13), 913-920, 2014 | 5 | 2014 |
| HCV reinfection among HIV patients after DAA therapy in the country of Georgia N Chkhartishvili, P Gabunia, A Abutidze, G Korkotashvili, O Chokoshvili, ... The annual Conference on Retroviruses and Opportunistic Infections (CROI), 8-11, 2020 | 4 | 2020 |
| Progress toward achieving the UNAIDS 90-90-90 goals in HIV care from diagnosis to durable viral suppression in the country of Georgia N Chkhartishvili, O Chokoshvili, A Abutidze, N Dvali, C Del Rio, ... AIDS Research and Human Retroviruses 33 (10), 999-1003, 2017 | 4 | 2017 |
| Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care E Ruadze, N Chkhartishvili, O Chokoshvili, T Tsertsvadze SAGE Open Medicine 5, 2050312117731977, 2017 | 4 | 2017 |
| Threat Characterization C (2012) Genomic comparison of Escherichia coli O104: H4 isolates from 2009 and 2011 reveals plasmid, and prophage heterogeneity, including shiga toxin … SA Ahmed, J Awosika, C Baldwin, KA Bishop-Lilly, B Biswas, S Broomall, ... PLoS One 7, e48228, 0 | 4 | |
| Hepatitis C care cascade for people living with HIV in the country of Georgia N Chkhartishvili, A Abutidze, N Bolokadze, O Chokoshvili, N Dvali, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 20, 11-12, 2017 | 3 | 2017 |
| Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus F Chammartin, A Mocroft, A Egle, R Zangerle, C Smith, C Mussini, F Wit, ... Clinical Infectious Diseases 78 (4), 995-1004, 2024 | 2 | 2024 |
Tengiz TsertsvadzeProfessor of Medicine, Ivane Javakhishvili Tbilisi State UniversityVerified email at gol.ge
